SKUNF (Seikagaku) Total Equity: $474.5 Mil (As of Mar. 2026)


SKUNF Seikagaku Corp SKUNF
66 GF Score
Price $4.44
GF Value $17.00
Valuation Significantly Undervalued
! 5 Warning Signs
View Full Analysis

What is Seikagaku Total Equity?

Seikagaku SKUNF +0.91% 66 Total Equity is $474.5 Mil as of Mar. 2026. GuruFocus rates SKUNF with a GF Score™ of 66/100 and a GF Value™ of $17.00 (Significantly Undervalued). The stock has 5 warning signs investors should review.

Seikagaku's total equity for the quarter that ended in Mar. 2026 was $474.5 Mil.

This is Residual interest, including minority interest, that remains in the assets of the enterprise after deducting its liabilities. Equity is increased by owners’ investments and by comprehensive income, and it is reduced by distributions to the owners.

Seikagaku Total Equity Historical Data

* Premium members only.

The historical data trend for Seikagaku's Total Equity can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Seikagaku Total Equity Chart

Seikagaku Annual Data
Trend Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23 Mar24 Mar25 Mar26
Total Equity
Get a 7-Day Free Trial Premium Member Only Premium Member Only 559.45 502.87 482.46 490.99 474.52

Seikagaku Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Total Equity Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 490.99 495.76 488.57 468.28 474.52
SKUNF
66GF Score
Seikagaku Corp SKUNF
Total Equity is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Seikagaku Total Equity Calculation

Total Equity and Total Liabilities are the two components for Total Assets.

Seikagaku's Total Equity for the fiscal year that ended in Mar. 2026 is calculated as

Total Equity=Total Assets(Q: Mar. 2026 )-Total Liabilities(Q: Mar. 2026 )
=544.13-69.611
=474.5

Seikagaku's Total Equity for the quarter that ended in Mar. 2026 is calculated as

Total Equity=Total Assets(Q: Mar. 2026 )-Total Liabilities(Q: Mar. 2026 )
=544.13-69.611
=474.5

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Total Equity →
What does a Total Equity of $474.5 Mil mean?
Seikagaku (SKUNF) has a Total Equity of $474.5 Mil as of Mar. 2026. The total amount of equity as record on a company's balance sheet. View historical data for Seikagaku and its competitors.
Is Seikagaku's Total Equity too high?
Seikagaku's current Total Equity is $474.5 Mil. Overall, Seikagaku has a GF Score™ of 66/100 and is considered Significantly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Seikagaku's Total Equity compare to ABT and SYK?
Seikagaku's Total Equity of $474.5 Mil can be compared against companies in the Medical Devices & Instruments industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Total Equity for a Medical Devices & Instruments company?
A good Total Equity depends on the Medical Devices & Instruments industry context. However, Total Equity should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Total Equity mean?
A high Total Equity can signal that a stock is expensive relative to its fundamentals. The total amount of equity as record on a company's balance sheet. View historical data for Seikagaku and its competitors. Seikagaku's current Total Equity is $474.5 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Seikagaku stock overvalued right now?
Based on GuruFocus' analysis, Seikagaku (SKUNF) is currently considered Significantly Undervalued. The stock's GF Value™ is $17.00, compared to a current price of $4.44 — trading 73.9% below its estimated fair value. The current Total Equity is $474.5 Mil. Seikagaku's overall GF Score™ is 66/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Total Equity calculated?
Total Equity is calculated from a company's financial statements. For Seikagaku (SKUNF), the current Total Equity is $474.5 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Seikagaku (SKUNF) Overvalued in 2026?

Based on GuruFocus' analysis, Seikagaku stock appears to be undervalued. The current stock price of $4.44 is trading 73.9% below its estimated GF Value™ of $17.00. GuruFocus considers Seikagaku to be Significantly Undervalued.

Key valuation signals for SKUNF:

  • Total Equity: $474.5 Mil
  • GF Value™: $17.00 vs. price of $4.44 (73.9% below fair value)
  • GF Score™: 66/100 with 5 warning signs

No single metric tells the full story. See the SKUNF stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Seikagaku Business Description

Other Exchanges 4548:Japan
Address Marunouchi Center Building 10 Floor, 6-1, Marunouchi 1-chome, Chiyoda-ku, Tokyo, JPN, 100-0005
Seikagaku Corp makes and sells pharmaceuticals and medical devices related to glycoconjugates. The firm operates in two segments: pharmaceutical and LAL. The pharmaceutical segment contributes the majority of revenue. This business sells pharmaceutical products made from hyaluronic acid, a major component of glycoconjugates, as well as medical devices and bulk products. The LAL segment manufactures endotoxin-detecting reagents made from limulus amebocyte lysate that are used to control quality in the pharmaceutical manufacturing process. Seikagaku generates the majority of its sales in Japan.
66GF Score

Get the complete analysis for SKUNF

Total Equity is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$4.44
Price
$17.00
GF Value